NDA 21555, held by Becton Dickinson Co. Chlorhexidine Gluconate; Isopropyl Alcohol.
As of Nov 14, 2026, NDA 21555 (Chloraprep One-Step Sepp, Chloraprep Single Swabstick, Chloraprep Triple Swabstick), held by Becton Dickinson Co, was first approved by FDA on Oct 7, 2002, with 14 approved supplements and 0 published complete response letters.
Use for the preparation of the patient's skin prior to surgery. Helps to reduce bacteria that potentially can cause skin infection.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 7, 2002 | Original applicationNew dosage form · Standard review | Approved |
| Chloraprep One-Step Sepp2%;70% (0.67ML) · swab;topical | Chlorhexidine Gluconate; Isopropyl Alcohol | OTCReference drug |
| Chloraprep Single Swabstick2%;70% (1.75ML) · swab;topical | Chlorhexidine Gluconate; Isopropyl Alcohol | OTCReference drug |
| Chloraprep Triple Swabstick2%;70% (5.25ML) · swab;topical | Chlorhexidine Gluconate; Isopropyl Alcohol | OTCReference drug |
| Aug 30, 2023 | Supplement 28Manufacturing | Approved | |
| Dec 22, 2017 | Supplement 20Manufacturing | Approved | |
| Sep 12, 2017 | Supplement 24Labeling · Standard review | Approved | |
| Jun 30, 2014 | Supplement 19Labeling · Standard review | Approved | |
| Oct 10, 2013 | Supplement 18Labeling · Standard review | Approved | |
| Aug 16, 2012 | Supplement 17Labeling · Standard review | Approved | |
| Aug 16, 2012 | Supplement 16Labeling · Standard review | Approved | |
| Jul 20, 2010 | Supplement 15Labeling · Standard review | Approved | |
| Mar 2, 2010 | Supplement 14Labeling · Standard review | Approved | None posted |
| Jun 10, 2009 | Supplement 3Manufacturing | Approved | |
| Aug 9, 2007 | Supplement 9Manufacturing | Approved | |
| Dec 20, 2006 | Supplement 7Labeling · Standard review | Approved | |
| Dec 27, 2005 | Supplement 5Manufacturing | Approved | |
| May 10, 2005 | Supplement 1Manufacturing · Standard review | Approved | |
| Oct 7, 2002 | Original applicationNew dosage form · Standard review | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters